Leo Pharma Announces Major Restructuring with Up to 250 Layoffs and Relocations

Layoffs and Relocations:
Leo Pharma is planning to eliminate or relocate up to 250 roles, with most of the affected jobs based in Denmark.

Restructuring Efforts:
The layoffs are part of a broader restructuring effort aimed at cost reduction and operational efficiency.

Additional Moves:
Besides the layoffs, 50 positions will be moved to Poland as part of the company's cost-cutting measures.

Industry Context:
The layoffs at Leo Pharma are part of a larger trend in the biopharma industry, with several companies announcing significant job cuts in recent months.

CEO's Revamp:
The restructuring is part of the CEO's revamp strategy to streamline the company's operations and improve its financial performance.